Radioimmunotherapy for Non-Hodgkin’s Lymphoma

ObjectivesTo describe the rationale for radioimmunotherapy as a treatment of non-Hodgkin’s lymphoma. To present the similarities and differences in the two radioimmunotherapies and the nursing implications in caring for patients receiving these agents.Data SourcesPublished literature and review of published clinical trials.ConclusionRadiolabeled monoclonal antibodies bind to specific antigens and provide a means of targeting tumor cells with cytotoxic radioactivity. The infusion of radiolabeled monoclonal antibodies requires an understanding of antibody therapy, radiation therapy, and principles of time, distance, and shielding.Implications for Nursing PracticeAs the use of radioimmunotherapy grows, nurses must be aware of the background for, logistics of, and follow-up required for patients receiving this form of radiation treatment.